| Title |
Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine
|
|---|---|
| Published in |
American Journal of Cardiovascular Drugs, October 2018
|
| DOI | 10.1007/s40256-018-0305-0 |
| Pubmed ID | |
| Authors |
Frédéric Lapostolle, Arnoud W. van’t Hof, Christian W. Hamm, Olivier Stibbe, Patrick Ecollan, Jean-Philippe Collet, Johanne Silvain, Jens Flensted Lassen, Wim M. J. M. Heutz, Leonardo Bolognese, Warren J. Cantor, Angel Cequier, Mohamed Chettibi, Shaun G. Goodman, Christopher J. Hammett, Kurt Huber, Magnus Janzon, Béla Merkely, Robert F. Storey, Jur ten Berg, Uwe Zeymer, Muriel Licour, Anne Tsatsaris, Gilles Montalescot |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 50% |
| Scientists | 1 | 25% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 120 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 16 | 13% |
| Researcher | 10 | 8% |
| Student > Bachelor | 10 | 8% |
| Student > Doctoral Student | 8 | 7% |
| Professor | 6 | 5% |
| Other | 28 | 23% |
| Unknown | 42 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 41 | 34% |
| Nursing and Health Professions | 7 | 6% |
| Unspecified | 6 | 5% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Other | 11 | 9% |
| Unknown | 50 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2023.
All research outputs
#8,607,480
of 25,554,853 outputs
Outputs from American Journal of Cardiovascular Drugs
#193
of 473 outputs
Outputs of similar age
#145,117
of 362,869 outputs
Outputs of similar age from American Journal of Cardiovascular Drugs
#3
of 5 outputs
Altmetric has tracked 25,554,853 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 473 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,869 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.